Carrot buys GreenMan's InSightVR to add cataract lens simulation
What's the deal? Carrot, the eye-care VR testing company formerly known as Virtual FieldDealroom has a profile for this one. Try Dealroom →, has agreed to acquire GreenMan VisionDealroom has a profile for this one. Try Dealroom →, the maker of InSightVRDealroom has a profile for this one. Try Dealroom →. Terms were not disclosed. The deal adds intraocular lens (IOL) simulation for cataract surgery to the Carrot Platform, pushing the company from vision diagnostics into vision simulation.
What each side does: Carrot sells VR visual field testing used in more than 2,500 clinics, from independent practices to enterprise networks. InSightVR, built by cataract surgeons Michael Greenwood and Brandon Baartman of Vance Thompson VisionDealroom has a profile for this one. Try Dealroom →, uses a patient's own biometry to place them inside everyday scenes — reading, night driving — to compare how different lenses could change their vision.
Why it matters: Cataract surgery is one of the most common operations in the US, and at its center is a lifelong choice of which lens goes in the eye. Most patients make that call from a conversation and a brochure, never seeing the tradeoffs.
What the data shows: In a 2026 retrospective study of 609 patients published in Patient Preference and Adherence , 57.1% of InSightVR patients chose an advanced-technology lens, compared with 28.4% under standard counseling. After surgery, 90% of surveyed patients who chose those lenses said their vision was similar to the simulation.
What changes for customers? Not much immediately. "Our customers will keep the same InSightVR team and the hands-on training and support they rely on," said Matt Larson, chief executive officer of GreenMan. "What will change is scale."
What's the endgame? Carrot already serves both the ophthalmology practices where cataract surgery happens and the optometry practices that refer patients to them. The deal lets it offer one partner from the first diagnostic exam to the lens a patient chooses for life.
The signal: The acquisition reflects a broader push to move VR in eye care beyond diagnostics and into patient decision-making. "When we became Carrot, we said we'd be defined by what we enable, not just what we measure," said Jeremy Barlow, chief executive officer of Carrot.
Read more: infomeddnews.com
Image credit: ex_magician
